Instituto Butantan to Produce CoronaVac Vaccine in Brazil, an Industrial Info Market Brief
Instituto Butantan to Produce CoronaVac Vaccine in Brazil, an Industrial Info Market Brief
Brazilian state company Instituto Butantan, with the financial support of Fundacao Butantan, is investing around $31 million at its Sao Paulo plant to produce 1.2 million units of the CoronaVac vaccine for COVID-19.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
